Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Synthetic Australian snake venom derivative effective for wound healing

June 17, 2004

Human serpin with potential to heal diabetic ulcers

June 16, 2004

Bradley Pharmaceuticals to acquire Bioglan

June 15, 2004

Cytomodulin promotes collagen transcription and wound healing in mice

June 14, 2004

New glucocorticosteroids prepared and tested at GSK

June 11, 2004

Orphan drug designation for Thymosin beta4 for epidermolysis bullosa

June 11, 2004

Leptin accelerates wound angiogenesis in vivo

June 7, 2004

Effective wound healing by topical application of novel preclinical therapeutic peptides

June 7, 2004

Topical vitamin B12 reported safe and effective in atopic dermatitis

June 4, 2004

Enrollment under way in confirmatory phase III trial of Sebazole

June 1, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.